Skip to main content
Fig. 2 | BMC Musculoskeletal Disorders

Fig. 2

From: The effect of calcium supplementation on calcium and bone metabolism during load carriage in women: protocol for a randomised controlled crossover trial

Fig. 2

Overview of load carriage exercise testing protocol.

aProcollagen type 1 N-terminal propeptide, bone-specific alkaline phosphatase, beta carboxy-terminal cross-linking telopeptide of type 1 collagen, albumin-adjusted calcium, ionized calcium, 44Ca:42Ca, phosphate, intact parathyroid hormone, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, luteinising hormone, follicle stimulating hormone, oestradiol, testosterone, and sex hormone binding globulin will be measured before load carriage.

bProcollagen type 1 N-terminal propeptide, beta carboxy-terminal cross-linking telopeptide of type 1 collagen, ionized calcium, albumin-adjusted calcium, phosphate, intact parathyroid hormone, sclerostin and osteocalcin will be measured at 0 and 120 min during load carriage, then 30 and 90 min after load carriage. 44Ca:42Ca will be measured at 120 min during load carriage.

cProcollagen type 1 N-terminal propeptide, beta carboxy-terminal cross-linking telopeptide of type 1 collagen, ionized calcium, albumin-adjusted calcium, phosphate, and intact parathyroid hormone will be measured at 20, 40, 60, 80 and 100 min during load carriage, and 15 and 60 min after load carriage.

Back to article page